Treatment For Psoriasis

AstraZeneca's revenue ambitions hit by psoriasis drug setback – Telegraph.co.uk

Telegraph.co.ukAstraZeneca's revenue ambitions hit by psoriasis drug setbackTelegraph.co.ukThe two companies have been sharing development of as a treatment for psoriasis, psoriatic arthritis and axial spondyloarthritis. The drug already faces competition from Eli Lily and Novartis who are targeting launch imminently and have reported no …AstraZeneca under pressure as Amgen cuts collaboration on potential …Proactive Investors USA & CanadaAmgen Ends Psoriasis-Drug Partnership With AstraZenecaWall Street JournalAmgen Ends Psoriasis-Drug Partnership With AstraZeneca — UpdateNasdaqReuters -Irish Timesall 96 news articles »

[monetize id=”1″]
[monetize id=”2″]

Scalp Treatment for Psoriasis

LEO Pharma reports encouraging data from PSO-FAST clinical trial of Enstilar … – News-Medical.net

European Pharmaceutical ReviewLEO Pharma reports encouraging data from PSO-FAST clinical trial of Enstilar …News-Medical.net"Itch can have a significant impact on the overall quality of life for psoriasis patients and having a well-tolerated and effective treatment option to rapidly relieve itch is important." The PSO-FAST clinical trial is a large, Phase 3, double-blind …New data shows Enstilar provides rapid itch relief for psoriasis patientsEuropean Pharmaceutical ReviewInvestigational Aerosol Foam Brings Rapid Itch Relief for Patients with PlaqueMD Magazineall 10 news articles »